MapLight Therapeutics (MPLT) Director Troy Cox Buys 15,620 Shares

What Happened
Troy Cox, a director of MapLight Therapeutics (MPLT), acquired 15,620 shares in an open-market purchase on July 28, 2026. The filing reports a weighted average price of $9.52 per share for a total value of $148,702. This was a purchase (accumulation) rather than a sale.

Key Details

• Transaction date: 2026-07-28 (Form 4 filed same day).
• Shares acquired: 15,620 shares via open market/private purchase (code P).
• Price: weighted average $9.52; actual trade prices ranged from $9.305 to $9.78 (see footnote).
• Total reported value: $148,702.
• Shares owned after transaction: not specified in this Form 4.
• Footnotes: F1 notes the weighted-average price and offers to provide a breakdown of shares at each price in the stated range; F2 states the shares are held by the "Troy M Cox & Adeo C Alday JT Revocable Trust dtd 5/28/25," of which Cox is co-trustee with voting and dispositive power.
• Timeliness: Filed on the same date as the reported transaction (no late-filing indication).

Context
This was an open-market purchase, which investors often view as a stronger signal than routine sales because it represents the insider adding to holdings. The purchase was executed in multiple trades (price range noted in F1) and the shares are held in a revocable trust where Cox shares control with his spouse. The filing contains no indication of option exercises, 10b5‑1 plan trades, or gifts.